Keywords: positve, data, targeted, genetics, tgaac95, firm, presented

Positve data on Targeted Genetics' tgAAC95

Article | 12 June 2006

Print This

US firm Targeted Genetics has presented interim data from its ongoing Phase I/II trial of tgAAC94 in patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in